| abstract |
Novel series of analogues of glucose-dependent insulinotropic polypeptides, pharmaceutical compositions comprising said compounds, and GIP receptor activation for the treatment of diseases mediated by GIP receptors such as non-insulin dependent diabetes and obesity There is provided the use of said compound as a drug or antagonist. [Selection] Figure 1 |